Survival after recurrence of Ewing's sarcoma family of tumors.
about
High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with first recurrence of Ewing sarcomaImproving Outcomes After Relapse in Ewing's Sarcoma: Analysis of 114 Patients From a Single InstitutionA flexible semiparametric modeling approach for doubly censored data with an application to prostate cancer.Integrated analysis of omics data using microRNA-target mRNA network and PPI network reveals regulation of Gnai1 function in the spinal cord of Ews/Ewsr1 KO mice.Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children's Oncology Group.Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma.Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy.Treatment pathway of bone sarcoma in children, adolescents, and young adultsThe genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation.Comparative evaluation of strategies for quantifying signaling pathway proteins in Ewing sarcoma.A study of docetaxel and irinotecan in children and young adults with recurrent or refractory Ewing sarcoma family of tumors.Current therapeutic approaches in metastatic and recurrent ewing sarcomaCopy Number Alterations and Methylation in Ewing's Sarcoma.Bone marrow cells participate in tumor vessel formation that supports the growth of Ewing's sarcoma in the lung.Targeting the Insulin-Like Growth Factor 1 Receptor in Ewing's Sarcoma: Reality and ExpectationsClinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group projectMolecular pathogenesis and targeted therapeutics in Ewing sarcoma/primitive neuroectodermal tumours.Late recurrence of a tumor of Ewing's sarcoma family of tumors: report of a case.SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma.The biology of ewing sarcomaEWING'S SARCOMA: EPIDEMIOLOGY AND PROGNOSIS FOR PATIENTS TREATED AT THE PEDIATRIC ONCOLOGY INSTITUTE, IOP-GRAACC-UNIFESPPilot Trial of FANG Immunotherapy in Ewing's Sarcoma.Dendritic cell-Ewing's sarcoma cell hybrids enhance antitumor immunity.Membrane expression of MRP-1, but not MRP-1 splicing or Pgp expression, predicts survival in patients with ESFT.Murine bone marrow-derived mesenchymal stem cells as vehicles for interleukin-12 gene delivery into Ewing sarcoma tumors.Ewing sarcoma: prognostic criteria, outcomes and future treatment.Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma.Pediatric developmental therapies: interesting new drugs now in early-stage clinical trials.Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology GroupCaveolin-1 promotes resistance to chemotherapy-induced apoptosis in Ewing's sarcoma cells by modulating PKCalpha phosphorylation.EWS-FLI-1 regulates the neuronal repressor gene REST, which controls Ewing sarcoma growth and vascular morphology.Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors.High-dose chemotherapy and stem cell rescue for high-risk Ewing's family of tumors.Sarcomas gone bad: what to do about recurrent Ewing sarcoma.Ewing sarcoma: clinical state-of-the-art.The effect of surgery with radiation on pelvic Ewing sarcoma survival.Prognostic significance of serum lactate dehydrogenase levels in Ewing's sarcoma: A meta-analysis.Three-year Follow up of GMCSF/bi-shRNA(furin) DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma.Post-relapse survival in patients with Ewing sarcoma.
P2860
Q24187643-041C3B2C-73BD-4D46-B5FD-A2EFFCABD5F8Q27496197-34B9DB43-30F8-4711-B05D-E6256DBB9081Q30658715-18A25C35-3C13-43DC-A342-454715079A72Q31122090-267B7385-1945-4ABC-AE81-1180A43E759DQ33381940-5A85ED01-BBBE-4622-9AAF-1CD734460911Q33404428-0041AE1E-181E-4A7F-9C62-708114FC6E55Q33418574-75563269-1446-4AAD-95FA-A6427661CCF0Q33835657-32A9C783-B250-4BD5-B434-C59AF9AD8CFCQ33881163-822E8BB7-9AA7-4277-AC6B-6FAADBE2CECBQ34105623-5C324310-62C3-4BAC-B5FF-75DD2A7C1B77Q34136875-EF02AC4F-E28D-46F9-9268-4C2FB3F02E9EQ34373180-85F46911-3713-4914-9A72-743BA7D9AA49Q34700651-74FA588D-DECE-4041-A765-AC968E7DC8E3Q34928239-19B844D7-0509-4F2F-AC36-48472986A6A6Q35013284-C25AAAA2-8CDF-444C-875E-F0436A146235Q35172207-6AB58EC5-289F-426C-A0E4-A0D0163D0EB0Q35957998-746D1740-C28C-4F65-83DA-48E0B9D4785CQ36028143-BB92F083-72DE-42AB-B85E-35E5989D36B4Q36069053-77D6E852-FBF4-46E9-AA72-9A01E8F633F2Q36546372-2717A3AB-4706-4E92-AB4E-1F9001D98ABFQ36705188-D235A990-01A5-4B40-B64F-16AAA4E9D61EQ36756669-2240AF45-A76B-4C55-99DA-E5497DB4266CQ36803613-2B86F644-CDAC-411E-8C62-E8B14D488BE5Q37003304-3103BFD7-CC06-433E-8F65-2504A69361EDQ37120256-22AB33BC-C9CD-42C6-90F4-526EF983C896Q37134450-D5CA4900-EDD0-499A-82CE-5059971A9455Q37256170-281CC09D-9AFE-4A52-85A7-E22E8A60CF80Q37301320-EEFABC5D-ACDF-411D-9BBB-28D3C004221FQ37308999-5CFA3742-6306-4CFA-9C2D-B19AF5F82AE8Q37480142-B80101E8-F8D2-4CEA-8B32-01CC727355F3Q37672300-93E64DD4-4C26-403E-B65C-5444AD44DF14Q37688646-B8AB512B-530E-4898-AFC7-7C08A7B4D713Q37716119-AA589BA8-C76F-48DF-9653-82322E8A1BF3Q37845833-FD8E64CD-870D-45CB-AAE5-152F5D9ACDCFQ37890995-E5EC4D4E-7240-4B76-B08B-2CA0B1E97C2BQ37980482-D93CEF92-58BD-4C11-8229-CF22F95A389BQ38622682-E580CB97-BF4B-494E-85F4-E166E01ABE50Q39095969-F7D7E8DB-0B3E-442A-B404-AA02B008F524Q41093026-161DC427-89EB-4DCE-8B65-C04EF7C2D9D4Q41587144-2EC1815C-E6FA-41CF-A3E2-9E8F761CA819
P2860
Survival after recurrence of Ewing's sarcoma family of tumors.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Survival after recurrence of Ewing's sarcoma family of tumors.
@ast
Survival after recurrence of Ewing's sarcoma family of tumors.
@en
type
label
Survival after recurrence of Ewing's sarcoma family of tumors.
@ast
Survival after recurrence of Ewing's sarcoma family of tumors.
@en
prefLabel
Survival after recurrence of Ewing's sarcoma family of tumors.
@ast
Survival after recurrence of Ewing's sarcoma family of tumors.
@en
P2093
P356
P1476
Survival after recurrence of Ewing's sarcoma family of tumors.
@en
P2093
Douglas S Hawkins
Jean E Sanders
Lisa M Barker
Thomas W Pendergrass
P304
P356
10.1200/JCO.2005.05.105
P407
P577
2005-03-21T00:00:00Z